Growing Number of Companies Developing New Products and Delivery Methods for Medical Cannabis

A growing number of companies are developing new products and delivery methods for medical cannabis. This includes new formulations of cannabis, such as inhalers and edibles, as well as new delivery methods, such as transdermal patches and vaporizers. These new products and delivery methods are making medical cannabis more accessible and appealing to patients. The growing number of companies developing new products and delivery methods for medical cannabis is a positive development for the industry and for patients. This innovation is making medical cannabis more accessible and appealing to a wider range of patients, and it is also helping to advance our understanding of the therapeutic potential of cannabis.

New Formulations

One of the most exciting areas of innovation is the development of new formulations of cannabis. These formulations are designed to improve the absorption, bioavailability, and onset of action of cannabis, as well as to reduce side effects. Some of the new formulations that are being developed include:

  • Inhalers: Inhalers deliver cannabis directly to the lungs, where it can be absorbed quickly into the bloodstream. This can provide faster relief from symptoms than other delivery methods.
  • Edibles: Edibles, such as gummies, chocolates, and mints, offer a convenient and discreet way to take cannabis. However, edibles can take longer to take effect than other delivery methods.
  • Topicals: Topicals, such as creams, lotions, and patches, are applied to the skin to relieve pain and inflammation.

New Delivery Methods

In addition to new formulations, there are also a number of new delivery methods being developed for medical cannabis. These new delivery methods are designed to make it easier for patients to take their medication and to improve the overall patient experience. Some of the new delivery methods that are being developed include:

  • Transdermal patches: Transdermal patches deliver cannabis through the skin, providing slow-release relief from symptoms.
  • Vaporizers: Vaporizers heat cannabis to a temperature below combustion, which produces a vapor that can be inhaled. This can reduce the amount of harmful chemicals that patients are exposed to.

Benefits of New Products and Delivery Methods

The development of new products and delivery methods for medical cannabis is having a number of benefits for patients, including:

  • Improved accessibility: New products and delivery methods are making medical cannabis more accessible to patients who may not have been able to take it in the past. For example, inhalers are a good option for patients who have difficulty swallowing or who have respiratory problems.
  • Increased appeal: New products and delivery methods are making medical cannabis more appealing to patients who may not have been comfortable taking it in the past. For example, edibles are a good option for patients who do not like to smoke or vape.
  • Advanced understanding of cannabis: The development of new products and delivery methods is helping us to better understand the therapeutic potential of cannabis. This is leading to the development of more effective and targeted treatments for a wider range of conditions.

Overall, the growing number of companies developing new products and delivery methods for medical cannabis is a positive development that is benefiting patients and advancing our understanding of this therapeutic plant

Indeed, the development of new products and delivery methods for medical cannabis is a rapidly evolving field. Companies are innovating to improve the absorption, bioavailability, and onset of action of cannabis, as well as to reduce side effects1. Here are some of the new formulations and delivery methods being developed:

New Formulations:

New Delivery Methods:

These advancements are making medical cannabis more accessible and appealing to a wider range of patients, and are also helping to advance our understanding of the therapeutic potential of cannabis1. If you have any other questions or need further information, feel free to ask!

Learn more:

1. link.springer.com2. leafbuyer.com3. health.state.mn.us4. emeraldmedicalgroup.com5. flmedcannabis.org6. leafbuyer.com7. shutterstock.com

Technological innovation and scientific research are rapidly transforming the medicinal cannabis industry. More companies are joining the race to develop new products and delivery systems, aiming to enhance the efficacy, safety, and convenience of cannabis-based therapeutics.

Innovative Product Types

Companies are moving beyond traditional cannabis products such as dry flower and developing innovative offerings such as cannabis-based pharmaceuticals, nutraceuticals, and cosmeceuticals. These product types allow companies to cater to specific patient populations and offer potentially higher margins than traditional cannabis products.

Cannabis-based pharmaceuticals involve isolating specific cannabinoids and delivering them in a controlled manner. Examples include Epidiolex, a CBD-based drug for treating severe forms of epilepsy, and Sativex, a THC:CBD oral spray for managing symptoms of multiple sclerosis.

Nutraceuticals blur the line between nutrition and pharmaceuticals, delivering beneficial compounds such as CBD and THC through food and beverage items. This category includes CBD-infused drinks, gummies, tinctures, and capsules, among others.

Cosmeceuticals are cosmetic products with bioactive ingredients – in this case, cannabinoids. Companies are weaving cannabinoids into products like anti-aging creams, moisturizers, and serums, capitalizing on their potential antioxidant and anti-inflammatory benefits.

Novel Delivery Methods

Along with diversifying their product offerings, companies are exploring novel delivery methods to enhance the bioavailability, onset time, and duration of effects of medicinal cannabis.

Nasal sprays and inhalers are under development, designed to offer a rapid onset of effects as the body absorbs active compounds through the lung and nasal membranes.

Transdermal patches, similar to nicotine patches, allow the slow release of cannabinoids into the bloodstream over several hours, providing a long-lasting and consistent delivery system. This method could appeal to patients using medicinal cannabis for chronic pain or other long-term conditions.

Another developing technology, nanoemulsion, breaks down cannabis oil into tiny particles, enabling cannabinoids to dissolve in water and enter the body quickly. This technology could revolutionize CBD-infused beverages and edibles by drastically improving the body’s absorption rate.

Regulatory Considerations

Product innovation in the medicinal cannabis industry is not without its regulatory challenges. Many novel product types and delivery methods fall into a gray area of cannabis regulation, demanding close engagement with regulatory bodies to ensure compliance. Furthermore, companies need rigorous scientific research backing their safety, efficacy, and consistency claims, making the product development process resource-intensive.

Nevertheless, the drive for innovation in medicinal cannabis continues to gain momentum as companies strive to meet growing patient demand, differentiate themselves in a competitive market, and capitalize on the immense therapeutic potential of cannabis. With continued technological advancement and regulatory progress, the landscape of medicinal cannabis is likely to keep evolving, bringing new possibilities for patient treatment and business growth.

  1. GW Pharmaceuticals: Their creation, Epidiolex, is a CBD-based drug that has been approved by the FDA for treating Lennox-Gastaut syndrome and Dravet syndrome, two severe forms of epilepsy in children. Sativex, another one of their developments, is a THC:CBD oral spray used for the management of multiple sclerosis symptoms.
  2. Medterra: A major player in the CBD nutraceutical space, Medterra offers CBD-infused capsules, gummies, and tinctures among other formats. They are praised for their product quality and commitment to full transparency, with detailed third-party lab reports for each product.
  3. HempFusion: This company offers CBD-infused topical products designed to support healthy skin. It claims that the CBD content helps to reduce inflammation and oxidative damage, key contributors to skin aging. Their offerings include face creams, body creams, balms, and ointments.
  4. Cannasouth: A New Zealand-based biopharmaceutical company developing medicines using proprietary nanoparticle and nanoemulsion technology to improve cannabinoid delivery and bioavailability. They aim to offer safe and effective medicines that can be easily absorbed by the body.
  5. XPhyto Therapeutics: XPhyto has developed a sublingual (under the tongue) thin-film delivery system that seeks to improve the bioavailability of cannabinoids. This could deliver more rapid relief for patients than traditional oral administration. Their primary focus is enhancing the efficacy of medicinal cannabis for cancer, epilepsy, and other debilitating conditions.
  6. Zelira Therapeutics: This pharmaceutical company has developed a new cannabinoid-based oral spray. The product, which offers precise dosing and rapid action, has undergone successful clinical trials for treating insomnia.
  7. Mary’s Medicinals: Known for their transdermal cannabis patch, Mary’s Medicinals provide a novel delivery method that releases a slow and consistent dose of cannabis over an extended period. They offer patches with different cannabinoid profiles to cater to various therapeutic needs.
  8. Canndescent: A California-based cannabis company that has introduced a unique CBD vaping product called “Stylus.” The innovation lies in the company’s use of ultra-high purity cannabinoid oils for a cleaner and more consistent vaping experience.
  9. Ebbu: Through premier research and development, Ebbu has made breakthroughs in formulation technologies and genomic advancements that result in reliable, consistent, and pure cannabis experiences. One example is their development of “hydroPS,” a cannabis technology that improves the solubility and bioavailability of cannabinoids in beverages.
  10. Willow Biosciences: This company focuses on producing ultra-pure, pharmaceutical-grade cannabinoids through biosynthesis – using yeast as the “factory” to convert sugar into cannabinoids. This has the potential to significantly reduce production cost and improve product purity compared to traditional plant cultivation.
  11. ZYUS: A Canada-based company, ZYUS is building the next-generation of cannabinoid-based formulations for high-impact medical conditions, addressing pain and inflammation management, mental health, neurology, and more.
  12. PAX Labs: Known widely for their technology in the electronic cigarette industry, PAX Labs has also made substantial inroads in the cannabis industry. Their PAX Era device provides control over temperature settings, enabling more personalized cannabis experiences.
  13. Ojai Energetics: This company has developed a water-soluble CBD tincture which allows for rapid absorption into the body within 30 seconds. The usual absorption rate for traditional oils is around 30 minutes, so this represents a significant advancement in delivery speed.
  14. 7ACRES: A division of Supreme Cannabis Company, they have developed sensory-based product categorization. The system, known as Aroma Flower Categories, classifies dried cannabis flowers based on their aroma profiles, offering an innovative approach to simplifying the product selection experience for consumers.
  15. CannabCo Pharmaceuticals: This Canadian company has developed a new technology, known as PURECANN, which reduces the distinctive smell of cannabis smoke. This is a novel approach to improving the user experience in markets where stealth or discretion is desirable.

These companies highlight the diverse and rapidly evolving nature of the medicinal cannabis industry, pushing boundaries to enhance product effectiveness, patient experience, and overall market growth.

Delta Cannabis Water: THC-infused beverage offering a refreshing and discreet way to consume cannabis.

Here are some images and links related to the companies and their products:

  1. Microsoft Bing:
  2. GW Pharmaceuticals Epidiolex:
  3. Medterra CBD products:
  4. HempFusion CBD-infused topical products:
  5. Cannasouth nanoparticle and nanoemulsion technology:
  6. XPhyto Therapeutics sublingual thin-film delivery system:
  7. Zelira Therapeutics cannabinoid-based oral spray:
  8. Mary’s Medicinals transdermal cannabis patch:
  9. Canndescent Stylus:
  10. Ebbu hydroPS:
  11. Willow Biosciences biosynthesis cannabinoids:

Learn more:

1. investor.jazzpharma.com2. pharmaceutical-technology.com3. investor.jazzpharma.com4. healthline.com5. healthline.com6. cbdviews.com7. businesswire.com8. businesswire.com9. cannabistech.com10. bionxt.com11. prnewswire.com12. globenewswire.com13. mattio.com14. extractionmagazine.com15. willowbio.com16. en.wikipedia.org17. self.com18. globenewswire.com19. medterracbd.com20. medicalnewstoday.com21. medterracbd.com22. prnewswire.com23. cbdclinicals.com24. news-medical.net25. pubs.rsc.org26. greencamp.com27. apnews.com28. wallstreetreporter.com29. bionxt.com30. zeliratx.com31. sprinjene.com32. pharmaceutical-technology.com33. marysmedicinals.com34. marysmedicinals.com35. entouragehealthcorp.com36. prnewswire.com37. markets.businessinsider.com38. terpenesandtesting.com39. drinkmemag.com40. terpenesandtesting.com41. willowbio.com42. growopportunity.ca43. theseedinvestor.com44. nutritioninsight.com

Categories: Uncategorized